Therefore, the purpose of our study was to investigate the differences in CT characteristics and disease spread patterns between patients with lung adenocarcinoma who have ROS1 rearrangement and those with EGFR mutations or ALK rearrangement. The gene discussed is ROS1; the disease is lung adenocarcinoma.